DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $124,000 | +12300.0% | 6,696 | +7871.4% | 0.00% | – |
| Q4 2021 | $1,000 | -98.1% | 84 | -94.6% | 0.00% | -100.0% |
| Q3 2021 | $53,000 | +55.9% | 1,553 | +163.7% | 0.00% | 0.0% |
| Q4 2020 | $34,000 | -35.8% | 589 | -43.4% | 0.00% | -66.7% |
| Q3 2020 | $53,000 | +17.8% | 1,041 | +44.6% | 0.01% | -45.5% |
| Q4 2019 | $45,000 | – | 720 | +6445.5% | 0.01% | – |
| Q3 2019 | $0 | -100.0% | 11 | -98.9% | 0.00% | -100.0% |
| Q2 2019 | $22,000 | +2100.0% | 959 | +3588.5% | 0.01% | – |
| Q4 2018 | $1,000 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |